Anatomical sNuffbox for Coronary anGiography and IntervEntions (ANGIE)

March 9, 2021 updated by: Grigorios Tsigkas, University Hospital of Patras
This randomized, single-center, prospective study seeks to compare the conventional radial approach with the recently described distal radial approach (anatomical snuffbox) concerning the patency of the radial artery in patients subjected to coronary angiography or percutaneous coronary intervention.

Study Overview

Detailed Description

Transradial approach has become the standard approach for coronary angiography (CAG) and percutaneous coronary intervention (PCI). The current ESC/EACTS guidelines of myocardial revascularization support using radial approach (RA) rather than femoral approach (FA) if the operators are experts for RA. Recently, an alternative transradial access has been suggested at the anatomical snuffbox, with potential additional benefits including a reduction in radial artery occlusion rate (which allows reintervention through the same access site and potential use as a graft), a decrease in other local vascular complications, shorter hemostasis duration, patients' intra and post procedural comfort and shorter recovery time. However, the feasibility of PCI via snuffbox approach is still concerned due to the lack of data. Therefore, the aim of the study is to compare the two approaches concerning the patency of the radial artery ≥30 days after the intervention with Doppler in a randomized way. Due to the anastomosis of the distal radial artery with the superficial palmar arch, even in case of total radial artery occlusion within the anatomical snuffbox, the antegrade blood flow may be preserved and, therefore, decreased incidents of radial artery occlusion are expected in the right distal radial artery approach group. The mean diameter of radial artery at the anatomical snuffbox is 2.4 mm, whereas the mean diameter of the radial artery at the forearm is 2.7 mm, and this could potentially contribute to shorter hemostasis duration.

Study Type

Interventional

Enrollment (Actual)

1042

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Achaia
      • Patras, Achaia, Greece, 26504
        • University Hospital of Patras

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Indication for coronary angiography
  • Informed consent

Exclusion Criteria:

  • Non palpable right radial artery
  • Prior complicated right transradial intervention (radial artery dissection, perforation, occlusion)
  • Prior CABG
  • STEMI
  • Hemodynamic instability
  • Anatomical restrictions (fistula, etc)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Conventional radial access
Comparison of the conventional radial approach with the distal radial approach (anatomical snuffbox)
EXPERIMENTAL: Distal radial access
Comparison of the conventional radial approach with the distal radial approach (anatomical snuffbox)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Rate of right radial artery occlusion
Time Frame: ≥30 days after CAG or PCI
≥30 days after CAG or PCI

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total Fluoroscopy time
Time Frame: Immediately post-procedurally
Immediately post-procedurally
Rate of successful insertion of the sheath
Time Frame: Immediately post-procedurally
Immediately post-procedurally
Duration of sheath insertion procedure
Time Frame: Immediately post-procedurally
Immediately post-procedurally
Rate of successful completion of coronary angiography
Time Frame: Immediately post-procedurally
Immediately post-procedurally
Rate of successful completion of percutaneous coronary intervention
Time Frame: Immediately post-procedurally
Immediately post-procedurally
Total Contrast volume
Time Frame: Immediately post-procedurally
Immediately post-procedurally
Total Radiation Dose
Time Frame: Immediately post-procedurally
Immediately post-procedurally
Total Procedure Time
Time Frame: Immediately post-procedurally
Immediately post-procedurally
Time required for hemostasis
Time Frame: 1-6 hours
1-6 hours
Postprocedural Hematoma (modified EASY class)
Time Frame: 3 hours
3 hours
Rate of distal radial artery occlusion
Time Frame: ≥30 days after CAG or PCI
≥30 days after CAG or PCI
Pain associated with the procedure: Pain scale 0-10
Time Frame: 1 hour
Pain scale 0-10. A visual anlog pain scale 0-10 will be shown to the patient post-precedurally. 0=no pain, 10=worst pain. Patient will be asked to report the severity of the pain associated with the procedure.
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 11, 2019

Primary Completion (ACTUAL)

February 20, 2021

Study Completion (ACTUAL)

February 20, 2021

Study Registration Dates

First Submitted

June 11, 2019

First Submitted That Met QC Criteria

June 13, 2019

First Posted (ACTUAL)

June 14, 2019

Study Record Updates

Last Update Posted (ACTUAL)

March 12, 2021

Last Update Submitted That Met QC Criteria

March 9, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Disease

Clinical Trials on Coronary angiography +/- percutaneous coronary intervention

Subscribe